AbCelex Technologies Inc., a Canadian biotechnology company, closed on $2.0m in Series A venture capital financing.
The round was led by Cultivian Sandbox Ventures, LP. Ron Meeusen, a Managing Director of Cultivian Sandbox and co-founder and Managing Partner of Cultivian Ventures, Matthew Bell, a Principal of Cultivian Sandbox, and Paul Dick, an animal health industry veteran, joined AbCelex Technologies’ Board of Directors.
The company intends to use the funds for research and development.
Led by President & CEO Dr. Saeid Babaei, AbCelex employs advanced genetics and bioengineering techniques to delivers antimicrobial solutions against various pathogens in several food animal species implicated in food-borne illnesses.
FinSMEs
28/04/2014